Association of the tumour necrosis factor α -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort

Genes and Immunity

Volumn 3, Issue 4, 2002, Pages 225-228

  Heijmans, B T ^a,b   Westendorp, R G J ^b   Droog, S ^a   Kluft, C ^a   Knook, D L ^a,b   Slagboom, P E ^a,b  

^a TNO   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiovascular disease; Diabetes mellitus; Linkage disequilibrium; Mortality; Polymorphism; Tumour necrosis factor

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

AGED; ALLELE; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FOLLOW UP; GENE EXPRESSION; GENETIC CODE; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HLA TYPING; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MORTALITY; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; GENE LINKAGE DISEQUILIBRIUM; GENETICS; NON INSULIN DEPENDENT DIABETES MELLITUS; PROMOTER REGION;

AGED; AGED, 80 AND OVER; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LINKAGE DISEQUILIBRIUM; MORTALITY; POLYMORPHISM, GENETIC; PROMOTER REGIONS (GENETICS); TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036616916     PISSN: 14664879     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.gene.6363859     Document Type: Article

References (26)

1. Barath P, Fishbein MC, Cao J, Berenson J, Helfant RH, Forrester JS. Detection and localization of tumor necrosis factor in human atheroma. Am J Cardiol 1990; 65: 297-302.
2. Lee RT, Libby P. The unstable atheroma. Arterioscler Thromb Vasc Biol 1997; 17: 1859-1867.
3. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science 1993; 259: 87-91.
4. Uysal KT, Wiesbrock SM, Marino MW, Hotamisligil GS. Protection from obesity-induced induced insulin resistance in mice lacking TNFα function. Nature 1997; 389: 610-614.
5. Hotamisligil GS, Arner P, Caro JF, Atkinson RL, Spiegelman BM. Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance. J Clin Invest 1995; 95: 2409-2415.
6. Nilsson J, Jovinge S, Niemann A, Reneland R, Lithell H. Relation between plasma tumor necrosis factor-α and insulin sensitivity in elderly men with non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1998; 18: 1199-1202.
7. Hotamisligil GS, Murray DL, Choy LN, Spiegelman BM. Tumor necrosis factor α inhibits signaling from the insulin receptor. Proc Natl Acad Sci USA 1994; 91: 4854-4858.
8. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW. Effects of a polymorphism in the human tumor necrosis factor α promoter on transcriptional activation. Proc Natl Acad Sci USA 1997; 94: 3195-3199.
9. Kroeger KM, Carville KS, Abraham LJ. The -308 tumor necrosis factor-α promoter polymorphism effects transcription. Mol Immunol 1997; 34: 391-399.
10. Louis E, Franchimont D, Piron A et al. Tumour necrosis factor (TNF) gene polymorphism influences TNF-α production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 1998; 113: 401-406.
11. Pociot F, Briant L, Jongeneel CV et al. Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-α and TNF-β by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus. Eur J Immunol 1993; 23: 224-231.
12. Brinkman BM, Zuijdeest D, Kaijzel EL, Breedveld FC, Verweij CL. Relevance of the tumor necrosis factor α (TNF α) -308 promoter polymorphism in TNF α gene regulation. J Inflamm 1995; 46: 32-41.
13. Herrmann SM, Ricard S, Nicaud V et al. Polymorphisms of the tumour necrosis factor-α gene, coronary heart disease and obesity. Eur J Clin Invest 1998; 28: 59-66.
14. Rich SS, Panter SS, Goetz FC, Hedlund B, Barbosa J. Shared genetic susceptibility of type 1 (insulin-dependent) and type 2 (non-insulin-dependent) diabetes mellitus: contributions of HLA and haptoglobin. Diabetologia 1991; 34: 350-355.
15. Tuomilehto-Wolf E, Tuomilehto J, Hitman GA et al. Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region. BMJ 1993; 307: 155-159.
16. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS. Genetic variability in the TNF-α promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 1995; 211: 833-839.
17. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARγ Pro12A1a polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26: 76-80.
18. Ferández-Real JM, Gutierrez C, Ricart W et al. The TNF-α gene Nco I polymorphism influences the relationship among insulin resistance, percent body fat, and increased serum leptin levels. Diabetes 1997; 46: 1468-1472.
19. Rasmussen SK, Urhammer SA, Jensen JN, Hansen T, Borch-Johnsen K, Pedersen O. The -238 and -308 G→A polymorphisms of the tumor necrosis factor ot gene promoter are not associated with features of the insulin resistance syndrome or altered birth weight in Danish Caucasians. J Clin Endocrinol Metab 2000; 85: 1731-1734.
20. Francis SE, Camp NJ, Dewberry RM et al. Interleukin-1 Receptor Antagonist Gene Polymorphism and Coronary Artery Disease. Circulation 1999; 99: 861-866.
21. Wang XL, Oosterhof J. Tumour necrosis factor α G-308→A polymorphism and risk for coronary artery disease. Clin Sci (Colch) 2000; 98: 435-437.
22. Weverling-Rijnsburger AW, Blauw GJ, Lagaay AM, Knock DL, Meinders AE, Westendorp RGJ. Total cholesterol and risk of mortality in the oldest old. Lancet 1997; 350: 1119-1123.
23. Wilson AG, de Vries N, Pociot F, di Giovine FS, van der Putte LB, Duff GW. An allelic polymorphism within the human tumor necrosis factor α promoter region is strongly associated with HLA A1, B8, and DR3 alleles. J Exp Med 1993; 177: 557-560.
24. O'Dell SD, Humphries SE, Day IN. Rapid methods for population-scale analysis for gene polymorphisms: the ACE gene as an example. Br Heart J 1995; 73: 368-371.
25. World Health Organization. International Classification of Diseases: Manual of the International Statistical Classification of Diseases, Injuries, and Causes of Death. World Health Organization: Geneva, 1977.
26. Schneider S, Kueffer JM, Roessli D, Excoffier L. Arlequin ver. 1.1: A Software for Population Genetic Data Analysis. Genetics and Biometry Laboratory, University of Geneva: Geneva, 1997.